vimarsana.com

Latest Breaking News On - சிண்டி காசெர்டா - Page 1 : vimarsana.com

WellAir Announces Appointment of Kieran Hannon as Chief Marketing Officer

WellAir Announces Appointment of Kieran Hannon as Chief Marketing Officer This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210310005059/en/ Kieran Hannon, Chief Marketing Officer, WellAir (Photo: Business Wire) Kieran is a globally recognized, creative and innovative business strategist. His expertise will be a valuable complement to our leadership team and a driving force in the expansion of the WellAir brand as we continue to advance our air cleaning and surface disinfection product portfolio globally, said Todd M. Pope, President and Chief Executive Officer at WellAir. Mr. Hannon brings over 30 years of experience in successfully building award-winning and world-class consumer experiences in the Internet of Things, mobile, digital and retail sectors. He joins WellAir from Openpath, a cloud access control company, where was Chief Marketing Officer. Previously, Mr. Hannon spent six years as Chief Marketing Officer at

WellAir Announces Acquisition of UV Innovators

WellAir Announces Acquisition of UV Innovators Todd M. Pope, Executive Chairman of UV Innovators appointed President and CEO of WellAir WellAir s flagship product, the Defend 1050, a portable air cleaning system which utilizes patented plasma-based technology, received U.S. FDA clearance in January 2021 WellAir, a leader in delivering clean air solutions to people around the world, today announced the acquisition of UV Innovators ( UVI ), a North Carolina-based developer of medical-grade handheld UVC disinfection technology. In addition, the company announced that Todd M. Pope, executive chairman of UV Innovators, has been appointed President and CEO of WellAir. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210210005235/en/

Novaerus Defend 1050 Cleared by FDA as 510(k) Class II Medical Device to Inactivate and Filter Out Airborne Virus and Bacteria for Medical Purposes

Posted on 463 Novaerus, a WellAir company that delivers clean air solutions to help prevent the spread of infectious outbreaks, announced today that the U.S. Food and Drug Administration (FDA) cleared the Novaerus Defend 1050 (NV 1050) as a 510(k) Class II Medical Device to inactivate and filter out micro-organisms, including virus and bacteria, for medical purposes. The Novaerus Defend 1050 is the first system that uses NanoStrike®, a patented plasma generating technology, to receive FDA 510(k) clearance. The Novaerus Defend 1050 is a free-standing, portable recirculating air cleaning system designed for additional frontline protection in healthcare settings such as operating rooms, intensive care units, in vitro fertilization labs, emergency rooms, waiting and treatment areas, neonatal units, and other critical environments including those performing aerosol-generating medical procedures (AGMP).

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.